Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

VINCRISTINE SULFATE INJECTION 1 MG

VINCRISTINE SULFATE : 1 MG · DIN 02324148 · ACCORD HEALTHCARE INC

Health Canada status: CANCELLED PRE MARKET

What is VINCRISTINE SULFATE INJECTION?

VINCRISTINE SULFATE INJECTION 1 MG contains VINCRISTINE SULFATE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02324148, held by ACCORD HEALTHCARE INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled pre market, status dated 07-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02324148
Brand nameVINCRISTINE SULFATE INJECTION
Generic / active ingredientVINCRISTINE SULFATE : 1 MG
ManufacturerACCORD HEALTHCARE INC
Strength1 MG
Dosage formSOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeL01CA02 VINCRISTINE
AHFS class10:00.00
BiosimilarNo
Health Canada statusCANCELLED PRE MARKET
Status date07-Aug-2017

Is VINCRISTINE in shortage in Canada?

A Canadian shortage report is on file for this molecule: Resolved — reported by TEVA CANADA LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for VINCRISTINE SULFATE INJECTION

What can be used instead?

Other Canadian products sharing ATC code L01CA02 VINCRISTINE. 2 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
VINCRISTINE SULFATE INJECTION1 MGSOLUTIONTEVA CANADA LIMITEDMARKETEDDIN 02143305
VINCRISTINE SULFATE INJECTION USP1 MGSOLUTIONPFIZER CANADA ULCMARKETEDDIN 02183013
ONCOVIN SOLUTION 1MG/ML1 MGLIQUIDELI LILLY CANADA INCCANCELLED POST MARKETDIN 00611182
VINCRISTINE SULFATE INJ 1MG/ML USP1 MGLIQUIDDAVID BULL LABORATORIES (PTY) LTD.CANCELLED POST MARKETDIN 00726575
VINCRISTINE SULFATE INJ 5MG/VIAL USP5 MGPOWDER FOR SOLUTIONDAVID BULL LABORATORIES (PTY) LTD.CANCELLED POST MARKETDIN 00690317
VINCRISTINE SULFATE INJECTION USP1 MGSOLUTIONUMAN PHARMA INCCANCELLED PRE MARKETDIN 02333198

Who else supplies VINCRISTINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. VINCRISTINE appears in 1989 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for VINCRISTINE SULFATE INJECTION

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for VINCRISTINE SULFATE INJECTION

Health Canada Drug Product Database (DPD), DIN 02324148. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.